HillCour is privately held with several operating companies primarily focused in healthcare. The company also has operations and majority/minority investments in technology, retail, real estate and pharmaceutical services.

Our primary objective is to maximize the return on capital employed while making transformative investments by leveraging our team's deep industry experience.

The company sold WellDyneRx to Carlyle in early 2017. More recently, the company was a significant investor in the IPO of Marpai, Inc. (NASDAQ: MRAI) in October 2021.